IDE849

IDE849 · IDEAYA Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IDE849, covering 2026-01-23 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer [Phase 1, Phase 2]